Skip to main content

MW 319.32 Da, Purity >99%. Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*.

Be the first to review this product! Submit a review

Images

Chemical Structure - SB 334867, OX1 receptor antagonist (AB120164), expandable thumbnail

Publications

Key facts

CAS number
249889-64-3
Purity
> 99%
Form
Solid
Molecular weight
319.32 Da
Molecular formula
C17H13N5O2
PubChem identifier
6604926
Nature
Synthetic

Alternative names

Recommended products

MW 319.32 Da, Purity >99%. Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*.

Key facts

Purity
> 99%
PubChem identifier
6604926
Solubility

Soluble in ethanol to 10 mM.

Soluble in DMSO to 100 mM.

Biochemical name
1-(2-Methylbenzo[d]oxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea
Biological description

Selective OX1 receptor antagonist. Inhibits orexin-A induced intracellular calcium release (IC50 = 226 nM). Shows anxiolytic, sedative and anorectic effects *in vivo.*

Canonical SMILES
CC1=NC2=C(O1)C=C(C=C2)NC(=O)NC3=C4C(=NC=C3)C=CC=N4
InChI
InChI=1S/C17H13N5O2/c1-10-20-12-5-4-11(9-15(12)24-10)21-17(23)22-14-6-8-18-13-3-2-7-19-16(13)14/h2-9H,1H3,(H2,18,21,22,23)
InChIKey
AKMNUCBQGHFICM-UHFFFAOYSA-N
IUPAC name
1-(2-methyl-1,3-benzoxazol-6-yl)-3-(1,5-naphthyridin-4-yl)urea

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions, The product can be stored for up to 12 months

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

The TDP1 protein also known as Tyrosyl-DNA Phosphodiesterase 1 plays a significant role in DNA repair by resolving DNA damage. This enzyme with a molecular mass of approximately 68 kDa is present in various tissues including the brain and peripheral tissues. Another target CYP2D6 an important enzyme in drug metabolism has a molecular mass of about 50 kDa and is predominantly found in the liver. In contrast Adenosine Receptor A2a a G protein-coupled receptor is distributed in the brain and blood vessels. The serotonin receptors 5-HT-2B and 5-HT2C also G-protein coupled reside in the central nervous system. Orexin Receptors 1 and 2 known as Ox-1-R and Ox-2-R respectively have an important presence in the brain particularly in the hypothalamus actively influencing wakefulness and appetite.

Biological function summary

The TDP1 enzyme helps maintain genomic integrity by repairing topoisomerase-induced DNA strand breaks and is not part of a larger complex. CYP2D6 significantly contributes to the metabolism of therapeutic drugs and toxins activating prodrugs into active compounds. The Adenosine Receptor A2a primarily mediates vasodilation and neuronal signaling often interacting with dopamine receptors. 5-HT-2B and 5-HT2C receptors modulate neurotransmitter release impacting mood and cognition. Orexin Receptors 1 and 2 critical for sleep regulation and feeding behavior interact with neuropeptides that control arousal and energy balance.

Pathways

TDP1 participates in the DNA repair pathway importantly counteracting damage due to DNA topoisomerase 1. This maintenance of DNA integrity aligns with proteins like PARP1 involved in the repair of single-strand breaks. CYP2D6 figures prominently in the xenobiotic metabolism pathway processing a wide array of exogenous substances alongside other cytochrome P450 enzymes. The Adenosine Receptor A2a is part of the cAMP signaling pathway interacting with important proteins like G-proteins to regulate various physiological processes. Serotonin receptor 5-HT-2B is associated with the serotonin signaling pathway interconnected with proteins modulating synaptic transmission. Orexin Receptors 1 and 2 are integral to the orexin/hypocretin pathway interacting with various signaling proteins to maintain energy homeostasis.

Associated diseases and disorders

TDP1 mutations associate with neurodegenerative diseases like spinocerebellar ataxia with axonal neuropathy (SCAN1) where DNA repair deficiencies manifest. PARP1 closely involved with TDP1 similarly associates with neurodegenerative conditions. Abnormal CYP2D6 activity results in varied drug metabolism linking it to disorders like depression and treatment-related adverse drug reactions. The Adenosine Receptor A2a has associations with Parkinson's disease impacting dopaminergic neurotransmission. In the realm of mood disorders the dysregulation of 5-HT2C receptors reveals a connection with obesity and type 2 diabetes highlighting its role in psychiatric conditions. Orexin Receptors 1 and 2 present connections to sleep disorders like narcolepsy impacting neuromodulators that regulate sleep-wake cycles.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

1 product image

  • Chemical Structure - SB 334867, OX1 receptor antagonist (ab120164), expandable thumbnail

    Chemical Structure - SB 334867, OX1 receptor antagonist (ab120164)

    2D chemical structure image of ab120164, SB 334867, OX1 receptor antagonist

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com